1.	研究成果回饋
	計畫主持人申請生物資料庫之檢體時，須至本院醫療資訊系統/人體生物資料庫/成果回饋登錄實驗目的、實驗方法，並須於計畫結束後一年內完成登錄實驗統計分析結果及原始數據等。為維護計畫主持人之智慧財產權，主持人可選擇研究成果對外公開時間，至多以登錄後三年為限。 若計劃結束後一年內，主持人未完成研究成果登錄，則暫停其申請生物資料庫檢體之案件，以及長庚醫院研究計畫至完成研究成果登錄。

---

2024年
申請單編號	成果回饋
2022031700001	Lin YH, Lin MH, Shi CS, Lin YS, Lin CL, Yang YH, Liao YS, Chen MY, Tsai MH, Lin MS. (2024). "The impact of fetuin-A on predicting aortic arch calcification: secondary analysis of a community-based survey." Front Cardiovasc Med. 2024 Jul 8;11:1415438.
2022111700001	Chen CH, Hsieh YY, Chen WM, Shen CH, Wei KL, Chang KC, Ding YJ, Lu SN, Hung CH, Chang TS. (2024). "Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan." Diagnostics (Basel). 2024 Jan 19;14(2):213.

2023年
申請單編號	成果回饋
2021050500001	Chen CH, Chen CJ, Huang YC, Huang PS, Chi HC, Chuang HC, Lin MH, Huang TH, Hsu JT, Chen CY. (2023). "Secreted Frizzled-Related Protein 4 Induces Gastric Cancer Progression and Resistance to Cisplatin and Oxaliplatin via β-Catenin

2022年
申請單編號	成果回饋
2020090700001	Lung, J., M. S. Hung, T. Y. Wang, K. L. Chen, C. W. Luo, Y. Y. Jiang, S. Y. Wu, L. W. Lee, P. Y. Lin, F. F. Chen, H. F. Liao and Y. C. Lin (2022). "Lipid Droplets in Lung Cancers Are Crucial for the Cell Growth and Starvation Survival." Int J Mol Sci 23(20).

2021年
暫無成果回饋

2020年
申請單編號	成果回饋
2020090700001	Hung MS, Lin YC, Chen FF, Jiang YY, Fang YH, Lu MS, Lin CK, Yang TM, Lung J, Chen CC, Lee KD, Tsai YH. The potential and limitation of targeted chromosomal breakpoint sequencing for the ROS1 fusion gene identification in lung cancer. Am J Cancer Res. 2022 May 15;12(5):2376-2386.

2019年
申請單編號	成果回饋
2019090500001	Sheng Feng Lin, Shui-Yi Tung, Chao-Hung Hung, et al. Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C. PLoS One 2020, 15(3):e0229994.

2018年
申請單編號	成果回饋
2018080300001	Sheng Feng Lin, Shui-Yi Tung, Chao-Hung Hung, et al. Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C. PLoS One 2020, 15(3):e0229994.
2018080200001	Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nature Communications 2019, 10(1).

2017年
申請單編號	成果回饋
2017120400001	Po-Shuan Huang, Chia-Siu Wang, Chau-Ting Yeh, et al. Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma. Int J Mol Sci 2019; 20(20):5220.

2016年
暫無成果回饋

2015年
申請單編號	成果回饋
2015121600001	Chih-Cheng Chen, Jie-Yu You, Jrhau Lung, et al. Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms. Haematologica 2017;Volume 102(3):509-518. Chih-Cheng Chen, Chia-Chen Hsu, Cih-En Huang, et al. Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke. Current Neurovascular Research, 2017, 14, 222-231.
2015011900002	Chih-Cheng Chen, Chia-Chen Hsu, Cih-En Huang, et al. Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke. Current Neurovascular Research, 2017, 14, 222-231.
2015011900001	Chih-Cheng Chen, Jie-Yu You, Jrhau Lung, et al. Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms. Haematologica 2017;Volume 102(3):509-518.